Albert Bourla, chairman and chief executive of global

Solution

Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a COVID-19 vaccine. The $1 million award is granted each year to a person for their professional achievements, contributions to humanity and commitment to Jewish values. The prize was inaugurated in 2014 and is run in a partnership between the private Genesis Prize Foundation and the chairman’s office of the Jewish Agency, a nonprofit group that has close ties to the Israeli government. It is funded by a $100 million endowment established by the foundation.